Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A Return on Equity

The latest ROE for HOVNP is 2.17%. That is above the Healthcare sector average of -75.84%. Investors often review this figure alongside Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, HOVNP currently prints 2.17% for ROE, while the sector average sits near -75.84%. That is roughly 102.9% above the sector mean. Large gaps often invite a closer look at Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's growth, margins, and balance sheet.

Return on Equity shows how effectively Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A converts resources into returns. At 2.17%, HOVNP may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting HOVNP's ROE (2.17%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.